These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 30604182)
1. Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies. Lisboa SF; Vila-Verde C; Rosa J; Uliana DL; Stern CAJ; Bertoglio LJ; Resstel LB; Guimaraes FS Psychopharmacology (Berl); 2019 Jan; 236(1):201-226. PubMed ID: 30604182 [TBL] [Abstract][Full Text] [Related]
2. Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation. Stern CAJ; de Carvalho CR; Bertoglio LJ; Takahashi RN Neuroscience; 2018 Feb; 370():62-80. PubMed ID: 28729064 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. Ganon-Elazar E; Akirav I Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741 [TBL] [Abstract][Full Text] [Related]
5. IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural Plasticity. Burgdorf J; Colechio EM; Ghoreishi-Haack N; Gross AL; Rex CS; Zhang XL; Stanton PK; Kroes RA; Moskal JR Int J Neuropsychopharmacol; 2017 Jun; 20(6):476-484. PubMed ID: 28158790 [TBL] [Abstract][Full Text] [Related]
6. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research. Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242 [TBL] [Abstract][Full Text] [Related]
7. Differential roles of the infralimbic and prelimbic areas of the prefrontal cortex in reconsolidation of a traumatic memory. Levin N; Kritman M; Maroun M; Akirav I Eur Neuropsychopharmacol; 2017 Sep; 27(9):900-912. PubMed ID: 28647452 [TBL] [Abstract][Full Text] [Related]
8. The endogenous cannabinoid system controls extinction of aversive memories. Marsicano G; Wotjak CT; Azad SC; Bisogno T; Rammes G; Cascio MG; Hermann H; Tang J; Hofmann C; Zieglgänsberger W; Di Marzo V; Lutz B Nature; 2002 Aug; 418(6897):530-4. PubMed ID: 12152079 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in hippocampal response to endocannabinoids after exposure to severe stress. Zer-Aviv TM; Akirav I Hippocampus; 2016 Jul; 26(7):947-57. PubMed ID: 26928784 [TBL] [Abstract][Full Text] [Related]
10. Stress and Fear Extinction. Maren S; Holmes A Neuropsychopharmacology; 2016 Jan; 41(1):58-79. PubMed ID: 26105142 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation? Mayo LM; Rabinak CA; Hill MN; Heilig M Biol Psychiatry; 2022 Feb; 91(3):262-272. PubMed ID: 34598785 [TBL] [Abstract][Full Text] [Related]
12. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers. de Bitencourt RM; Pamplona FA; Takahashi RN Neuropharmacology; 2013 Jan; 64():389-95. PubMed ID: 22687521 [TBL] [Abstract][Full Text] [Related]
13. The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event. Shoshan N; Akirav I Neurobiol Learn Mem; 2017 Oct; 144():248-258. PubMed ID: 28818702 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. Burstein O; Shoshan N; Doron R; Akirav I Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):129-139. PubMed ID: 29458190 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies. Lisboa SF; Stern CAJ; Gazarini L; Bertoglio LJ Int Rev Neurobiol; 2024; 177():235-250. PubMed ID: 39029986 [TBL] [Abstract][Full Text] [Related]
16. Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus. Uniyal A; Singh R; Akhtar A; Bansal Y; Kuhad A; Sah SP Pharmacol Biochem Behav; 2019 Oct; 185():172763. PubMed ID: 31445955 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials. de Quervain D; Wolf OT; Roozendaal B Psychopharmacology (Berl); 2019 Jan; 236(1):183-199. PubMed ID: 30610352 [TBL] [Abstract][Full Text] [Related]
19. Fear extinction and BDNF: translating animal models of PTSD to the clinic. Andero R; Ressler KJ Genes Brain Behav; 2012 Jul; 11(5):503-12. PubMed ID: 22530815 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Ganon-Elazar E; Akirav I J Neurosci; 2009 Sep; 29(36):11078-88. PubMed ID: 19741114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]